Financial Life Planners Buys New Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Financial Life Planners bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 156 shares of the medical equipment provider’s stock, valued at approximately $81,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Bennett Selby Investments LP grew its holdings in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after acquiring an additional 17 shares in the last quarter. LVW Advisors LLC boosted its stake in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. grew its holdings in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after buying an additional 19 shares in the last quarter. FSM Wealth Advisors LLC increased its holdings in shares of Intuitive Surgical by 3.7% during the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC raised its position in shares of Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after buying an additional 19 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Jamie Samath sold 269 shares of the stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,727,816.73. The trade was a 2.98 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 28,843 shares of company stock valued at $15,357,560 in the last ninety days. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Trading Down 1.4 %

Intuitive Surgical stock opened at $571.88 on Monday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The firm has a 50-day moving average price of $550.40 and a 200-day moving average price of $510.02. The firm has a market capitalization of $203.69 billion, a PE ratio of 89.22, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39.

Analyst Ratings Changes

ISRG has been the subject of several research reports. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. BTIG Research raised their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Truist Financial upped their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.